CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) Prepares for Increased Cannabis Demand in Canada

Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018. The company’s focus on the development of proprietary research and products utilizing cannabis-derived botanical oils addresses two areas of key interest to consumers: the noted health benefits of cannabinoids and smoke-free alternatives for marijuana consumption. An article discussing this reads: “Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once legalization takes place. The company cites a 2016 Mackie Research Capital Corp. estimate involving trends in Colorado, one of the first U.S. states to legalize marijuana, which found that 45% of dried marijuana users would eventually convert to marijuana extracts and/or oils. Algae Dynamics’ strategy includes extracting oils from cannabis and hemp to formulate unique health and nutraceutical products, along with the distinction of becoming a leading medical cannabis producer through its association with two of Canada’s leading research universities – the University of Waterloo and the University of Western Ontario. This collaborative research is focused on the use of extracts from cannabis oil in the context of various forms of cancer, in addition to development of new pharmacotherapies for mental health.”

To view the full article, visit

About Algae Dynamics Corp.

ADC is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focused on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. For more information, visit

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

Leave a Reply